Preview: Rigel Pharmaceuticals's Earnings

Preview: Rigel Pharmaceuticals's Earnings

Rigel Pharmaceuticals RIGL is set to give its latest quarterly earnings report on Thursday, 2022-11-03. Here's what investors need to know before the announcement.

Analysts estimate that Rigel Pharmaceuticals will report an earnings per share (EPS) of $-0.13.

Rigel Pharmaceuticals bulls will hope to hear the company to announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Historical Earnings Performance

Last quarter the company beat EPS by $0.04, which was followed by a 8.46% increase in the share price the next day.

Here's a look at Rigel Pharmaceuticals's past performance and the resulting price change:

Quarter Q2 2022 Q1 2022 Q4 2021 Q3 2021
EPS Estimate -0.12 -0.14 -0.13 -0.10
EPS Actual -0.08 -0.16 -0.11 -0.12
Price Change % 8.46% 6.45% 21.12% -2.52%

Quarter Q2 2022 Q1 2022 Q4 2021 Q3 2021
EPS Estimate -0.12 -0.14 -0.13 -0.10
EPS Actual -0.08 -0.16 -0.11 -0.12
Price Change % 8.46% 6.45% 21.12% -2.52%

Stock Performance

Shares of Rigel Pharmaceuticals were trading at $0.7532 as of November 01. Over the last 52-week period, shares are down 78.41%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.

To track all earnings releases for Rigel Pharmaceuticals visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: BZI-EPEarnings